Irwin Naturals and Braxia Scientific Sign Letter of Intent Entering Partnership to Launch In-Human Clinical Studies to Support Pharmaceutical Sponsors Across U.S.

Toronto, Ontario--(Newsfile Corp. - January 10, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC PINK: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders, is proud to announce it has signed a Letter of Intent entering into a partnership with Irwin Naturals Inc. ("Irwin") (CSE: IWIN) (OTC: IWINF) (FRA: 97X) to launch Clinical Research Services across Irwin's...

2023-01-10 7:46 AM EST

Get News by Email

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Braxia Scientific Corp. or all companies in the Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Psychedelics industry.

Stock Quote

Financial Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

RSS Feeds

Our last 10 news releases for Braxia Scientific Corp. in RSS format are available for public consumption. Full text RSS feeds which can be categorized by type and industry are available upon request.

Regulatory Filings

View SEDAR Documents

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Braxia Scientific Corp.

Recent News

Irwin Naturals and Braxia Scientific Sign Letter of Intent Entering Partnership to Launch In-Human Clinical Studies to Support Pharmaceutical Sponsors Across U.S.

Ready to Announce with Confidence?